Evox Therapeutics has appointed Dr Antonin “Tony” de Fougerolles as CEO. Tony joins from Ablynx NV, where he held the role of chief scientific officer for four years. Prior to this, he was chief scientific officer of Moderna Therapeutics where he was instrumental in helping build out Moderna’s early pipeline, platform, and intellectual property estate, as well as helping secure a $240 million upfront deal with AstraZeneca with additional milestones, including $180 million in technical milestones, commercial milestones, and high single to double digit royalties.